Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 109, Issue 3, 2010, Pages

  Mori, Yoshiyuki ^a   Ogasawara, Toru ^a   Motoi, Toru ^b   Shimizu, Yuichiro ^a   Chikazu, Daichi ^a   Tamura, Kazumi ^a   Fukumoto, Seiji ^a   Takato, Tsuyoshi ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 23; TUMOR PROTEIN;

ADULT; ARTICLE; BLOOD; CASE REPORT; FOLLOW UP; HUMAN; HYPOPHOSPHATEMIA; MALE; MAXILLA TUMOR; MESENCHYMOMA; METABOLISM; OSTEOMALACIA; PARANEOPLASTIC SYNDROME; PATHOLOGY; TREATMENT OUTCOME;

ADULT; FIBROBLAST GROWTH FACTORS; FOLLOW-UP STUDIES; HUMANS; HYPOPHOSPHATEMIA; MALE; MAXILLARY NEOPLASMS; MESENCHYMOMA; NEOPLASM PROTEINS; OSTEOMALACIA; PARANEOPLASTIC SYNDROMES; TREATMENT OUTCOME;

EID: 77449129427     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2009.10.052     Document Type: Article

References (16)

1. Ahn J.-M., Kim H.-J., Cha C.-M., Kim J., Yim S.-G., and Kim H.J. Oncogenic osteomalacia: induced by tumor, cured by surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 (2007) 636-641
2. Lewiecki E.M., Urig Jr. E.J., and Williams Jr. R.C. Tumor-induced osteomalacia: lessons learned. Arthritis Rheum 58 (2008) 773-777
3. Folpe A.L., Fanburg-Smith J.C., Billings S.D., Bisceglia M., Bertoni F., Cho J.Y., et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 28 (2004) 1-30
4. Ruppe M.D., and Jan de Beur S.M. Disorders of phosphate homeostasis. In: Rosen C.J. (Ed). Primer on the metabolic diseases and disorders of mineral metabolism, seventh edition (2008), American Society of Bone and Mineral Research, Washington (DC) 317-325 editor-in-chief
5. Shimada T., Mizutani S., Muto T., Yoneya T., Hino R., Takeda S., et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A 98 (2001) 6500-6505
6. Jonsson K.B., Zahradnik R., Larsson T., White K.E., Sugimoto T., Imanishi Y., et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348 (2003) 1656-1663
7. Fukumoto S., and Yamashita T. FGF23 is a hormone-regulating phosphate metabolism-unique biological characteristics of FGF23. Bone 40 (2007) 1190-1195
8. Takeuchi Y., Suzuki H., Ogura S., Imai R., Yamazaki Y., Yamashita T., et al. Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia. J Clin Endocrinol Metab 89 (2004) 3979-3982
9. Yamazaki Y., Okazaki R., Shibata M., Hasegawa Y., Satoh K., Tajima T., et al. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 87 (2002) 4957
10. Jan de Beur S.M. Tumor-induced osteomalacia. JAMA 294 (2005) 1260-1267
11. Ogura E., Kageyama K., Fukumoto S., Yagihashi N., Fukuda Y., Kikuchi T., et al. Development of tumor-induced osteomalacia in a subcutaneous tumor, defined by venous blood sampling of fibroblast growth factor-23. Intern Med 47 (2008) 637-641
12. Nasu T., Kurisu S., Matsuno S., Tatsumi K., Kakimoto T., Kobayashi M., et al. Tumor-induced hypophosphatemic osteomalacia diagnosed by the combinatory procedures of magnetic resonance imaging and venous sampling for FGF23. Intern Med 47 (2008) 957-961
13. Nuovo M.A., Dorfman H.D., Sun C.C., and Chalew S.A. Tumor-induced osteomalacia and rickets. Am J Surg Pathol 13 (1989) 588-599
14. Rendina D, De Filippo G, Tauchmanova L, Insabato L, Muscariello R, Gianfrancesco F, et al. Bone turnover and the osteoprotegerin-RANKL pathway in tumor-induced osteomalacia: a longitudinal study of five cases. Calcif Tissue Int. Published online Sep. 10, 2009.
15. Ratanasuwan T., Chetsurakarn S., Ongphiphadhanakul B., and Damrongkitchaiporn S. A case report of tumor-induced osteomalacia: eight year followed-up. J Med Assoc Thai 91 (2008) 1900-1902
16. Zimering M.B., Caldarella F.A., White K.E., and Econs M.J. Persistent tumor-induced osteomalacia confirmed by elevated postoperative levels of serum fibroblast growth factor-23 and 5-year follow-up of bone density changes. Endocr Pract 11 (2005) 108-114